Androgen receptor expression and breast cancer mortality in a population-based prospective cohort

PURPOSE: The increase in clinical trials with androgen receptor (AR)-targeting drugs emphasizes the need of clarifying the role of AR expression in different breast cancer subtypes. AR confers good prognosis in estrogen receptor positive (ER+) breast cancer, but its role in ER-negative (ER−) breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Elebro, Karin, Bendahl, Pär-Ola, Jernström, Helena, Borgquist, Signe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602002/
https://www.ncbi.nlm.nih.gov/pubmed/28643022
http://dx.doi.org/10.1007/s10549-017-4343-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602002/
https://www.ncbi.nlm.nih.gov/pubmed/28643022
http://dx.doi.org/10.1007/s10549-017-4343-0

Ejemplares similares